← Back to Search

Nursing home residents with moderate to severe dementia for Pain

N/A
Recruiting
Led By Wingyun Mak, PhD
Research Sponsored by PainChek Ltd
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up throughout the study on multiple occasions, on average every 7 days
Awards & highlights

Study Summary

Pain is common amongst people living with dementia. However, as people's dementia worsens their ability to self-report pain diminishes because of limitations in their cognition and communication abilities. As a result pain in people with moderate to severe dementia often goes under-recognised and undertreated. PainChek® is a technology-enabled, observational pain assessment tool, in the form of a mobile application designed specifically to assist healthcare professionals and professional caregivers assess pain in people with moderate severe dementia. In this study the investigators aim to assess the performance of PainChek® in assessing pain in nursing home residents with moderate to severe dementia compared to the Abbey Pain Scale.

Eligible Conditions
  • Pain
  • Dementia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~throughout the study on multiple occasions, on average every 7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and throughout the study on multiple occasions, on average every 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in pain score using Abbey Pain Scale
Change in pain score using PainChek Adult
Other outcome measures
Change in heart rate using a finger pulse oximeter
Change in respiratory rate using a finger pulse oximeter

Trial Design

1Treatment groups
Experimental Treatment
Group I: Nursing home residents with moderate to severe dementiaExperimental Treatment1 Intervention
Simultaneous pain assessments using PainChek® and the Abbey Pain Scale undertaken by two independent pain assessors, blinded to each others results

Find a Location

Who is running the clinical trial?

PainChek LtdLead Sponsor
Donawa Lifescience Consulting SRLUNKNOWN
TechnoSTAT Clinical ServicesUNKNOWN
~60 spots leftby Jun 2025